AMGEN Inc risk profile

47 Elevated one input has moved against it

Measured 21 October 2026 from AMGN's filed statements. Recomputed nightly.

47 (Elevated), driven by Concentration at 69, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation22NormalStableOne-year price volatility — 29.4%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversion24NormalWorseningCash conversion — 1.29x
Leverage and coverage49ElevatedEasingNet debt to EBITDA — 3.19x
Competitive position42ElevatedStableOperating-margin gap against peers — -0.8 percentage points
Concentration69StretchedStableGeographic concentration — 5,168 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for AMGEN Inc